Navigation Links
Apple’s Face ID Security Available in Mobile App for Clinical Trial Management
Date:11/6/2018

Crucial Data Solutions announces the latest update to their native mobile app for clinical trial data collection and management. TrialKit™, an eClinical platform, has incorporated Apple’s biometric technologies for user authentication. Now, iPhone users with compatible generation devices can quickly and easily sign in to the app via facial recognition or fingerprint recognition.

Regulatory compliant (FDA 21 CFR Part 11) research studies are reimagined when the latest mobile health (mHealth) technology meets facial recognition technology. By using Face ID®, research professionals have faster, more secure access to TrialKit to build, manage, and analyze studies. They will no longer worry that their username and password may fall into the wrong hands or lost devices where the user opted to stay signed in.

Likewise, study participants using TrialKit to complete electronic patient-reported outcomes (ePRO) will feel more comfortable inputting data for a clinical trial. This will create a more robust audit trail and offer streamlining in the adjudication of trial data. In turn, this should also help improve patient compliance and engagement rates. Researchers and patients access the same app and are therefore protected by the same security measures.

Data security is always a concern on the clinical research front. This new method of authentication safeguards sensitive patient data at an unmet level. The likelihood of someone being able to access any given user’s iPhone via Face ID is 1 in 1,000,000. Authentication using Face ID provides 1024 bit encryption - data security that paper-based clinical studies or studies using simple password data encryption cannot achieve. This exceeds National Institute of Standards and Technology (NIST) standards by utilizing encryption that is several thousand times greater than this current standard. NIST recommends the use of Advanced Encryption Standard (AES) 128, 192 or 256-bit encryption, OpenPGP, and S/MIME.

And, according to Apple’s Face ID Security Guide, apps that use Face ID are notified “only as to whether the authentication was successful; it can’t access Face ID or the data associated with the enrolled face.” Users of TrialKit can be confident that the app cannot access any Face ID data associated with the device.

Study administrators will also have the ability to enforce exclusive biometric authentication. This means all the users and participants, within a study, will be required to sign in with Touch ID® or Face ID and restricted from the old email/password identification system. Mandating the use of face recognition technology will help curb false authentications and maintain data integrity.

When reached for comment about the future of Face ID in clinical settings, Dr. Leigh J Mack, CMO at Crucial Data Solutions, elaborates, “Currently, facial recognition systems are currently being used in some medical check-in systems at oncology clinics. The main advantage of facial recognition system for clinical trials are:

  • Higher level of data and personal information security
  • True participant recognition - not someone else logging in to report a result or outcome, e.g., provider or medical staff when the participant is supposed to provide the information
  • Dosage accountability - single use dosage (UPC with specific serial number) could be scanned along with the face of participant for elevated compliance.”

TrialKit is available on the App Store® today and can also be found on Google Play for Android devices. TrialKit on Android currently has support for fingerprint authentication, and is awaiting Android mobile support for facial recognition being available to third party apps. Rest assured, TrialKit will be onboard as soon as it’s made available.

About Crucial Data Solutions, Inc.
Crucial Data Solutions, Inc. is a forward-thinking company dedicated to developing innovative technologies that reduce the cost of medical research by equipping clinical professionals with the tools they need to advance treatments that enable patients with life-altering conditions to lead better lives. We believe clinical research should be a true partnership between ourselves, research professionals, caregivers, and patients worldwide.

Android is a trademark of Google LLC
Google Play is a trademark of Google LLC

Read the full story at https://www.prweb.com/releases/apples_face_id_security_available_in_mobile_app_for_clinical_trial_management/prweb15895561.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Parks Associates: More Than 26 Million U.S. Broadband Households Will Have Professionally Monitored Security by 2021
2. Assured Enterprises Expands its Digital Security Platform, Partnering with Qafis Ltd, TeeBase UK Ltd. and C3 Security Inc.
3. PathSensors Demonstrates Breakthrough Mail Security Screening Solution at National Postal Forum 2017
4. Assured Enterprises and Qafis Biometrics Enhance Digital-Based Security Protections Worldwide
5. PathSensors Launches Low Cost, High Speed Anthrax and Bio Threat Detection Solution for Mail Security Screening
6. Nordion and General Atomics Welcome US National Nuclear Security Administration Phase II Funding for New, Reliable Source of Molybdenum-99
7. Call for Papers for Pittcon 2017 Technical Program - Emphasis on Food Safety, Homeland Security, Bioanalytical Science and Nano-imaging
8. Smallpox Virus as Terrorist Bioweapon: New Thriller “Deadly Pages” by Dr. Leslie Norins Blends Riveting Fiction with Chilling National Security Warning
9. New Genedata Profiler Release Strengthens Data Security and Patient Privacy in Translational Research
10. Morf Media Inc. Releases 2016 HIPAA Best Practices Course with NICS and Cybersecurity on Morf Playbook for Mobile Devices and PCs
11. Mast Announces Amendment To Loan And Security Agreement With Hercules Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2019)... ... ... adopted from a local shelter when he was around two years old. According to ... after he was adopted, he tore his right cruciate ligament. Though he had his ... a traumatic injury. , Sure enough, when Rascal was about nine years old, he began ...
(Date:1/8/2019)... ... 08, 2019 , ... The American Society of Gene and Cell Therapy’s ... selection committee made up of industry leaders identified by the ASGCT board of directors. ... awards created to support ASGCT members designing transformative pilot studies in gene and cell ...
(Date:1/4/2019)... SUNNYVALE, Calif. (PRWEB) , ... January 02, 2019 ... ... a proprietary technology to detect precancer and cancer cells in blood, has been ... Medigen Biotech , a global biotech company developing cell therapies for cancer treatment, ...
(Date:12/19/2018)... ... 19, 2018 , ... RURO, Inc., a leading provider of ... 7.1. The new release enhances the latest version of Limfinity®, RURO’s software framework, ... end. , Validation protocols, and their execution, are critical for software systems scrutinized ...
Breaking Biology Technology:
(Date:12/18/2018)... ... December 18, 2018 , ... CP Merritt is a ... been competing for many years however in 2006, he had a medical setback that ... was determined that he suffered from cartilage degeneration in his right rear fetlock. ...
(Date:12/13/2018)... ... December 12, 2018 , ... Illumina, Kaiser Permanente, ResMed and Aetna were just ... Diego-based team-building and cooking events company has hosted an impressive guest list of Fortune ... , Each group who visits receives a completely customized experience, right down to ...
(Date:12/6/2018)... ... December 06, 2018 , ... Stewart has been ... contract services, throughout his career. During his recent five-year tenure with InSphero he ... established the commercial laboratory operations in Brunswick, Maine. Through these experiences, Stewart has ...
Breaking Biology News(10 mins):